UBS AM’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.46M | Sell |
|
|||||
|
2025
Q2 | $12.7M | Buy |
|
|||||
|
2025
Q1 | $12.8M | Buy |
|
|||||
|
2024
Q4 | $5.51M | Buy |
|
|||||
|
2024
Q3 | $4.7M | Sell |
|
|||||
|
2024
Q2 | $3.89M | Buy |
|
|||||
|
2024
Q1 | $1.84M | Buy |
|
|||||
|
2023
Q4 | $1.94M | Hold |
|
|||||
|
2023
Q3 | $1.35M | Sell |
|
|||||
|
2023
Q2 | $2.27M | Hold |
|
|||||
|
2023
Q1 | $2.27M | Buy |
|
|||||
|
2022
Q4 | $2.36M | Buy |
|
|||||
|
2022
Q3 | $1.55M | Sell |
|
|||||
|
2022
Q2 | $855K | Sell |
|
|||||
|
2022
Q1 | $1.04M | Sell |
|
|||||
|
2021
Q4 | $1.11M | Buy |
|
|||||
|
2021
Q3 | $730K | Sell |
|
|||||
|
2021
Q2 | $1.16M | Buy |
|
|||||
|
2021
Q1 | $899K | Hold |
|
|||||
|
2020
Q4 | $651K | Buy |
|
|||||
|
2020
Q3 | $289K | Sell |
|
|||||
|
2020
Q2 | $463K | Sell |
|
|||||
|
2020
Q1 | $387K | Buy |
|
|||||
|
2019
Q4 | $352K | Sell |
|
|||||
|
2019
Q3 | $571K | Buy |
|
|||||
|
2019
Q2 | $293K | Buy |
|